Natural Health Trends (NHTC) Q3 2024 earnings summary

Executive summary

• Q3 2024 net sales were $10.7 million, up 1% year-over-year, with sequential growth despite weak consumer spending in the main market.

• Net income for Q3 2024 was $35,000 (breakeven per diluted share), down from $172,000 last year; nine-month net income was $396,000, up from $210,000.

• Operating loss improved for three consecutive quarters, with Q3 2024 loss at $275,000, better than $292,000 in Q3 2023.

• Active member base declined to 30,880 at September 30, 2024, down 11% year-over-year.

• Hong Kong accounted for 78% of Q3 net sales, with most revenue from products delivered to members in China.

Financial highlights

• Gross profit margin was 74.1% in Q3 2024, down from 74.7% in Q3 2023, due to higher costs for premium products.

• Net cash used in operating activities was $3.5 million for the first nine months, improved from $4.2 million a year ago.

• Excluding a required tax payment, $514,000 in cash flow was generated from operations, a $1.7 million improvement year-over-year.

• Cash, cash equivalents, and marketable securities totaled $46.3 million at September 30, 2024, down from $48.7 million at June 30, 2024.

• Quarterly cash dividends of $0.20 per share were paid, totaling $6.9 million for the first nine months.

Outlook and guidance

• Focus remains on product innovation, digital enhancement, market expansion, and training to drive future growth.

• Digital enhancement project rollout is anticipated early next year to boost member productivity and sales experience.

• Management believes existing liquidity is adequate to fund operations and commitments.

• Strategic initiatives aim to return to a healthy growth phase and deliver shareholder value.

• Ongoing efforts include customer engagement, trainings, product roadshows, and new product launches.